Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MGX | CLUSTER | neutral | 2/10 | Three insiders at Metagenomi Therapeutics (MGX) sold a total of $9K in open-market shares on June 5, 2026, representing | Jun 11, 2026 |
| ADTX | CLUSTER | bearish | 6/10 | Two 10% owners sold a combined ~$52K in ADTX stock over a 7-day window, with HRT Financial LP selling $46K and Gong Sand | Jun 10, 2026 |
| AXSM | CLUSTER | neutral | 4/10 | CEO Herriot Tabuteau and CFO Nick Pizzie sold a combined ~$19.9M in open-market sales on June 9, 2026, following derivat | Jun 10, 2026 |
| INM | CLUSTER | bullish | 7/10 | Two 10% owners (Vivo Opportunity, LLC and ADAR1 Capital Management, LLC) purchased a combined $189K of INM stock in an 8 | Jun 10, 2026 |
| ANIP | CLUSTER | neutral | 3/10 | CFO Stephen Carey exercised and sold option shares in a same-day cashless transaction on June 5, and a director sold a s | Jun 10, 2026 |
| ONC | CLUSTER | neutral | 2/10 | BeOne Medicines Ltd. (ONC) insiders executed a small cluster of open-market sales totaling $1.49M over eight days, led b | Jun 10, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | A small insider selling cluster at United Therapeutics (UTHR) saw the CEO, CFO, and EVP/GCO sell a combined ~$1.23M in o | Jun 10, 2026 |
| NUVL | CLUSTER | neutral | 3/10 | Nuvalent CEO James Porter exercised 30,000 options at $18.93/share and sold 12,495 shares on the open market for $1.1M, | Jun 10, 2026 |
| MGX | CLUSTER | neutral | 2/10 | Two insiders (both See Remarks) sold a combined $5,579 in open-market sales on June 5, 2026, at $1.299/share. The aggreg | Jun 10, 2026 |
| REX | CLUSTER | neutral | 4/10 | Two REX insiders sold a total of ~$718K in stock within a 7-day window. The $614K sale by Executive COB Stuart Rose at $ | Jun 10, 2026 |
| MIRM | CLUSTER | neutral | 3/10 | Three Mirum insiders, including the CEO and CFO, sold a total of $854K in open-market sales over a one-week window. The | Jun 9, 2026 |
| ABEO | CLUSTER | bearish | 5/10 | A cluster of insider sales at ABEO Therapeutics: CEO, CFO, Chief Commercial Officer, and Chief Legal Officer collectivel | Jun 9, 2026 |
| TOI | CLUSTER | neutral | 2/10 | A mixed insider cluster at Oncology Institute (TOI) shows a $126K open-market sale by the CMO and a $57K open-market pur | Jun 9, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Three top insiders at United Therapeutics, the CEO, CFO, and General Counsel, executed a cluster of open-market sales to | Jun 9, 2026 |
| NBIX | CLUSTER | neutral | 3/10 | A cluster of insider selling at Neurocrine Biosciences over the past week totals $4.53M in open-market sales by four off | Jun 9, 2026 |
| NBIX | CLUSTER | neutral | 2/10 | Four insiders at Neurocrine Biosciences sold a total of $4.53M in stock over a one-week window, including the Chief Scie | Jun 9, 2026 |
| TNXP | CLUSTER | bullish | 4/10 | CEO Seth Lederman and Director Richard Stillwell each purchased $59K and $58K worth of TNXP shares in open-market transa | Jun 9, 2026 |
| AXSM | CLUSTER | neutral | 4/10 | CEO Herriot and CFO Pizzie exercised stock options and immediately sold the resulting shares in open-market transactions | Jun 9, 2026 |
| IPSC | CLUSTER | neutral | 2/10 | Two insiders at Century Therapeutics sold small open-market positions totaling ~$1.6K on June 8, 2026, while the CEO had | Jun 9, 2026 |
| ADPT | CLUSTER | neutral | 3/10 | Two C-suite insiders at Adaptive Biotechnologies sold a combined $893K in open-market transactions within a 7-day window | Jun 8, 2026 |
| CING | CLUSTER | neutral | 3/10 | Five Cingulate insiders, including the CEO, CFO, and CMO, made open-market purchases totaling $44K over Feb 6-13, 2026. | Jun 8, 2026 |
| USNA | CLUSTER | neutral | 3/10 | Two insiders at USANA Health Sciences sold a combined $147K in open-market transactions over a one-week window, represen | Jun 8, 2026 |
| NBIX | CLUSTER | neutral | 4/10 | A cluster of insider selling at Neurocrine Biosciences, totaling ~$4.5M over a week, is dominated by C-suite officers ex | Jun 8, 2026 |
| LQDA | CLUSTER | neutral | 3/10 | Four Liquidia Corp insiders, all directors and one CHRO, sold a total of $4.26M in open-market transactions over a 7-day | Jun 8, 2026 |
| KROS | CLUSTER | neutral | 2/10 | Two Keros Therapeutics directors sold a combined $56K in open-market sales on June 4, 2026, following a round of non-cas | Jun 8, 2026 |
| LQDA | CLUSTER, 8-K | neutral | 5/10 | LQDA has been selected for addition to the S&P SmallCap 600 Index, effective prior to the opening of trading on June 22, | Jun 8, 2026 |
| TEVA | CLUSTER | neutral | 2/10 | Two senior Teva executives, the CEO and an EVP, sold a combined $744K in open-market stock over a three-day window along | Jun 8, 2026 |
| KRYS | CLUSTER | neutral | 2/10 | President and CEO Krishnan Krish S and President of R&D Krishnan Suma each sold 320 shares of Krystal Biotech on June 4, | Jun 5, 2026 |
| XERS | CLUSTER | neutral | 3/10 | Two Xeris insiders (Director Persky and officer Hecht) sold a combined $192K in open-market sales over a 3-day window. T | Jun 5, 2026 |
| XERS | CLUSTER | neutral | 3/10 | A cluster of insider selling at Xeris Biopharma, totaling $192K in open-market sales by two directors and an officer, oc | Jun 5, 2026 |